The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Sukiasyan S.G.

«Artmed» Medical Rehabilitation Center;
Armenian Medical Institute

Soldatkin V.A.

Rostov State Medical University

Snedkov E.V.

Mechnikov North-West State Medical University;
St. Petersburg Psychiatric Hospital of St. Nicholas

Tadevosyan M.Ya.

«Artmed» Medical Rehabilitation Center;
Armenian Medical Institute

Kryuchkova M.N.

Rostov State Medical University

Combat-related posttraumatic stress disorder: the historical evolution of concept from «irritable heart syndrome» to «psycho-organic disorder». Biological aspect

Authors:

Sukiasyan S.G., Soldatkin V.A., Snedkov E.V., Tadevosyan M.Ya., Kryuchkova M.N.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2020;120(7): 149‑156

DOI: 10.17116/jnevro2020120071149

Read: 5009 times

Download PDF (RU)
Contact the author
Table of contents

COMBAT-RELATED POSTTRAUMATIC STRESS DISORDER: THE HISTORICAL EVOLUTION OF CONCEPT FROM «IRRITABLE HEART SYNDROME» TO «PSYCHO-ORGANIC DISORDER». BIOLOGICAL ASPECT
COMBAT-RELATED POSTTRAUMATIC STRESS DISORDER: THE HISTORICAL EVOLUTION OF CONCEPT FROM «IRRITABLE HEART SYNDROME» TO «PSYCHO-ORGANIC DISORDER». BIOLOGICAL ASPECT

To cite this article:

Sukiasyan SG, Soldatkin VA, Snedkov EV, Tadevosyan MYa, Kryuchkova MN. Combat-related posttraumatic stress disorder: the historical evolution of concept from «irritable heart syndrome» to «psycho-organic disorder». Biological aspect. S.S. Korsakov Journal of Neurology and Psychiatry. 2020;120(7):149‑156. (In Russ.)
https://doi.org/10.17116/jnevro2020120071149

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Gene­tic variants asso­ciated with the deve­lopment of stress diso­rders: A systematic review of GWAS. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3):12-26
Stress and sleep: Neurobiological aspe­cts and modern options of inso­mnia therapy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5-2):14-21
Depression Anxiety Stress Scale (russian language version). S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):103-107
Inve­stigation of the rela­tionship of indi­vidual characteristics of the brain bioelectrical acti­vity with levels of mental stress, aggression, anxiety, and depression. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):108-117
Mental diso­rders in mili­tary personnel at the stage of medi­cal care in a multidisciplinary mili­tary medi­cal orga­nization. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(6):37-44
The rela­tionship between neighborhood infrastructure and stress levels in students. Russian Journal of Preventive Medi­cine. 2024;(11):70-76
Atopic dermatitis and skin toxic reactions: comparative characteristics, psychosomatic aspe­cts and patient mana­gement tactics. Russian Journal of Clinical Dermatology and Vene­reology. 2024;(6):744-752
Nutrition correction in the complex therapy and reha­bilitation of the posttraumatic stress diso­rder. Russian Journal of Preventive Medi­cine. 2025;(2):114-119
Impact of the COVID-19 epidemic on students’ health. Part II. Features of hemo­dynamics, vege­tative regu­lation, resu­lts of psychological and stress resi­stance testing among students depe­nding on the COVID-19 presence in their medi­cal history. Russian Journal of Preventive Medi­cine. 2025;(4):94-101
Socio-psychological and personal risk factors of stress deve­lopment in students. Russian Journal of Preventive Medi­cine. 2025;(6):81-87
Abstract:

OBJECTIVE

To study a role of traumatic brain injury (TBI) in the development of posttraumatic stress disorder (PTSD) in ex combatants.

MATERIAL AND METHODS

Eighty-seven ex combatants were studied. The duration of follow-up was 15—18 years. The diagnosis was established in accordance with ICD-10 criteria. Patients were stratified by diagnosis into main group (PTSD) and comparison group (organic brain injury with reduced symptoms of PTSD). A psychopathological method and a battery of questionnaires and scales, including those adapted for assessment of consequences of combat trauma, were administered.

RESULTS AND CONCLUSION

Clinical presentations of both groups in posttraumatic period show the similarity and homogeneity of posttraumatic disorders in these groups. In the future, the pathogenetic role of TBI severity appears more clearly, which, depending on the severity, leads to the formation of an organic lesion of the brain or performs only a pathoplastic role, giving some features to the clinical picture of PTSD. It was found that the more severe the injury, the greater the likelihood of PTSD transition to organic brain damage. It is emphasized that PTSD treatment is a continuous, long-term, complex and graded process that includes pharmacotherapy, psychopharmacotherapy, psychotherapy, psychosocial interventions.

Keywords:

posttraumatic stress disorder
somatization of psychiatric disorders
exogenous organic disorder
brain injury

Authors:

Sukiasyan S.G.

«Artmed» Medical Rehabilitation Center;
Armenian Medical Institute

Soldatkin V.A.

Rostov State Medical University

Snedkov E.V.

Mechnikov North-West State Medical University;
St. Petersburg Psychiatric Hospital of St. Nicholas

Tadevosyan M.Ya.

«Artmed» Medical Rehabilitation Center;
Armenian Medical Institute

Kryuchkova M.N.

Rostov State Medical University

Received:

07.04.2019

Accepted:

15.08.2019

Close metadata

References:

  1. Lents A. War and Hysterical Stigmata. Psikhiatr gazeta. 1915;10:152-155. (In Russ.).
  2. Sukhanov SA. Wartime psychopathies. Russkii vrach. 1915;34:800-804. (In Russ.).
  3. Gilyarovskii VA. The old and new problems of psychitary. M.: Medgiz; 1946. (In Russ.).
  4. Snezhnevskii AV. To the clinic of brain injury by blast wave. Tr. Tsentr. in-ta psikhiatrii MZ RSFSR. T. 3. M.: Iz-vo Moskovskogo NII psikhiatrii;1947. (In Russ.).
  5. Lermoyez M. Deafness in war (Referat A. Grachevoi). Psikhiatr gazeta. 1915;18:294-295. (In Russ.).
  6. Osipov VP. Issues of psychiatric practice of wartime. L.: Gosud. izd-vo med. literatury; 1941. (In Russ.).
  7. Gol’man SV. Psychoses and Psychoneuroses of Wartime. Pod red. Osipova V.P. L.: Gosud. izd-vo med. literatury; 1941. (In Russ.).
  8. Sarkisov DS, Gel’fand VB, Tumanov VP. Problems of early diagnosis of human diseases. Klinicheskaya meditsina. 1993;7:6-14. (In Russ.).
  9. Oppenheim H. Die traumatischen Neurosen. Berlin. 1889.
  10. Sukhanov SA. Psychoneuroses of Wartime. Ros. psikhiatr. zhurnal. 1997;2:68-73. (In Russ.).
  11. Bekhterev VM. War and psychoses. Obozr. psikhiat., nevrol. i eksperim. psikhol. 1914/1915;19(4-6):317-335. (In Russ.).
  12. Ivanov FI. Forms of psychogenic reactions in wartime. Voen.-med. zhurn. 1964;2:45-47. (In Russ.).
  13. Appel JW. Incidence of neuropsychiatric disorders in World War II. Amer J Psychiatry. 1946;102(4):433-466. 
  14. Yurman NA. Wartime neurasthenic psychoses. Psikhiatr. gazeta. 1915;9:139-142. (In Russ.).
  15. McDaniel EG. Psychological response to disasters. Medicine for disaster. Ed. by Baskett P., Weller R. London; Boston: Wright; 1988.
  16. Myasishchev VN. Psychogenic and encephalopathies. Tr. Tsentr. in-ta psikhiatrii MZ RSFSR. M.: Iz-vo Moskovskogo NII psikhiatrii; 1947. (In Russ.).
  17. Khoroshko VK. About mental disorders as a result physical and shock during war. Psikhiatr gazeta. 1916;1:3-10. (In Russ.).
  18. Gannushkin PB. Works of the Psychiatric Clinic (Devich’e Pole). M.: Izd-vo M. i S. Sabashnikovykh; 1926. (In Russ.).
  19. Krasnushkin EK. Wartime Psychiatry Problems. M.: Iz-vo bol’nitsy im. Kashchenko P.P.; 1945. (In Russ.).
  20. Yudin TI. Amentia and Neurasthenia. Sovetskaya psikhonevrologiya. 1935;4-5:78-82. (In Russ.).
  21. Gerver AV. About mental disorders in the theater of wartime operations. Russkii vrach. 1915;34:793-800; 35:817-821; 36:841-844. (In Russ.).
  22. Petrov VF, Lukomskii MI, Kovalenko PA, Kurbangaliev RI. Specialized medical assistance in combat pathology. M.: Voenizdat; 1991. (In Russ.).
  23. Gurvits TV, Lasko NB, Schachter SC, Kuhne AA, Orr SP, Pitman RK. Neurological status of Vietnam veterans with chronic posttraumatic stress disorder. J Neuropsychiatry Clin Neurosci. 1993;5(2):183-188. 
  24. Friedman, Charney & Deutch. Neurobiological and Clinical Consequences of Stress: From Normal Adaptation to PostTraumatic Stress Disorder. Philadelphia: Lippincott-Raven; 1995.
  25. McEwen BS. Neurobiological and clinical consequences of stress: From normal adaptation to PTSD. Philadelphia. 1995.
  26. Yehuda R. Psychoneuroendocrinology of post-traumatic stress disorder. Psychiatric Clinics of North America. 1998;21(2):359-379. 
  27. Gurvits TV, Shenton ME, Hokama H, Ohta H, Lasko NB, Gilbertson MW, Orr SP, Kikinis R, Jolesz FA, McCarley RW, Pitman RK. Magnetic resonance imaging study of hippocampal volume in chronic, combat related posttraumatic stress disorder. Biol Psychiatry. 1996;40:1091-1099. https://doi.org/10.1016/S0006-3223(96)00229-6
  28. Gilbertson MW, Shenton ME, Ciszewski A, Kasai K, Lasko NB, Orr SP, Pitman RK. Smaller hippocampal volume predicts pathologic vulnerability to psychological trauma. Nature Neuroscience. 2002;5:1242-1247.
  29. Bremner JD. Hypotheses and controversies related to effects of stress on the hippocampus: an argument for stress-induced damage to the hippocampus in patients with posttraumatic stress disorder. Hippocampus. 2001;11:75-81. 
  30. Kasai K. Evidence for acquired pregenual anterior cingulate gray matter loss from a twin study of combat-related posttraumatic stress disorder. Biology Psychiatry. 2008;63:550-556.  https://doi.org/10.1016/j.biopsych.2007.06.022
  31. Carrion VG. Decreased prefrontal cortical volume associated with increased bedtime cortisol in traumatized youth. Biological Psychiatry. 2010;68:491-493. 
  32. Soldatkin VA, Sukiasyan SG, Galkin KYu. Post-traumatic stress disorder: who is in the sight? Kontsept. 2014;2. Accessed November 28, 2018 (In Russ.). https://e-koncept.ru/2014/54366.htm
  33. Post-traumatic stress disorder. Pod red. Soldatkina V.A. Rostov-n/D: Izd-vo RostGMU; 2015. (In Russ.).
  34. Soldatkin VA, Bukhanovskii AO, Kalmykov EA. Neuroimaging brain characteristics of the patients suffering from game addiction. Rossiiskii psikhiatricheskii zhurnal. 2011;1:15-22. (In Russ.).
  35. Geuze E, Westenberg HGM, Heineck A, de Kloet CS, Goebel R, Vermetten E. Thinner prefrontal cortex in veterans with posttraumatic stress disorder. NeuroImage. 2008;41:3:675-681.  https://doi.org/10.1016/j.neuroimage.2008.03.007
  36. Simonov PV. Emotional brain. M.: Nauka; 1981. (In Russ.).
  37. Southwick SM, Bremner D, Krystal JH, Charney DS. Psychobiologic research in post-traumatic stress disorder. Psychiatric Clinics of North America. 1994;17(2):251-264. 
  38. Kolb LC. A neuropsychological hypothesis explaining posttraumatic stress disorders. The American Journal of Psychiatry. 1987;144(8):989-995. 
  39. Van der Kolk BA, Greenberg M, Boyd H, Krystal J. Inescapable shock, neurotransmitters, and addiction to trauma: Toward a psychobiology of post-traumatic stress. Biol Psychiat. 1985;20:314-325. 
  40. Meerson FZ, Pshennikova MG. Adaptation to stress situations and physical loads. M.: Meditsina; 1988. (In Russ.).
  41. Kryuchkova MN, Soldatkin VA. Chronic pelvic pain syndrome: psychopathological aspects. Vestnik urologii. 2017;5(1):52-67. (In Russ.).
  42. Hamner MB, Hitri A. Plasma beta-endorphin levels in post-traumatic stress disorder: a preliminary report on response to exercise-induced stress. J Neuropsychiatry Clin Neurosci. 1992;4(1):59-63. 
  43. Strawn JR, Geracioti TD. Jr. Noradrenergic dysfunction and the psychopharmacology of posttraumatic stress disorder. Depression and Anxiety. 2008;25:3:260-271.  https://doi.org/10.1002/da.20292
  44. Koob GF. Corticotropin-releasing factor, norepinephrine, and stress. Biol Psychiatry. 1999;46:1167-1180.
  45. Geuze E, van Berckel BNM, Lammertsma AA, Boellaard R, de Kloet CS, Vermetten E, Westenberg H.M. Reduced GABAA benzodiazepine receptor binding in veterans with post-traumatic stress disorder. Molecular Psychiatry. 2008;13:74-83. 
  46. Murrough JW, Huang Y, Hu J, Henry S, Williams W, Gallezot J-D, Bailey ChR, Krystal JH, Carson RE, Neumeister A. Reduced amygdala serotonin transporter binding in posttraumatic stress disorder. Biological Psychiatry. 2011;70:1033-1038. https://doi.org/10.1007/978-3-642-40384-2_13
  47. Schelling G, Kilger E, Roozendaal B, de Quervain DJ-F, Briegel J, Dagge A, Rothenhäusler H-B, Krauseneck T, Nollert G, Kapfhammer H-P. Stress doses of hydrocortisone, traumatic memories, and symptoms of posttraumatic stress disorder in patients after cardiac surgery: a randomized study. Biological Psychiatry. 2004;55:627-633.  https://doi.org/10.1016/j.biopsych.2003.09.014
  48. Mason JW, Wang S, Yehuda R, Lubin H, Johnson D, Bremner JD, Charney D, Southwick S. Marked lability in urinary cortisol levels in subgroups of combat veterans with posttraumatic stress disorder during an intensive exposure treatment program. Psychosom Med. 2002;64(238-246).
  49. Baker DG, West SA, Nicholson WE, Ekhator NN, Kasckow JW, Hill KK, Bruce AB, Orth DN, Geracioti TD. Serial CSF corticotropin-releasing hormone levels and adrenocortical activity in combat veterans with posttraumatic stress disorder. Am J Psychiatry. 1999;156:585-588. 
  50. Dunn AJ, Berridge CW. Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses? Brain Research Reviews. 1990;15:71-100.  https://doi.org/10.1016/0165-0173(90)90012-D
  51. Goodyer IM, Park RJ, Netherton CM, Herbert J. Possible role of cortisol and dehydroepiandrosterone in human development and psychopathology. Br J Psychiatry. 2001;179:243-249.  https://doi.org/10.1192/bjp.179.3.243
  52. Horger BA, Roth RH. Stress and central amino acid systems. Philadelphia: Lippincott-Raven; 1998.
  53. Geracioti TD, Baker DG, Ekhator NN, West SA, Hill KK, Bruce AB, Schmidt D, Rounds-Kugler B, Yehuda R, Keck PE, Kasckow JW. CSF Norepinephrine Concentrations in Posttraumatic Stress Disorder. Am J Psychiatry. 2001;158(8):1227-1230. https://doi.org/10.1176/appi.ajp.158.8.1227
  54. Pietrzak RH, Gallezot J-D, Ding Yu-Sh, Henry Sh, Potenza MN, Southwick SM, Krystal JH, Carson RE, Neumeister A. Association of Posttraumatic Stress Disorder With Reduced In Vivo Norepinephrine Transporter Availability in the Locus Coeruleus. JAMA Psychiatry. 2013;70(11):1199-1205.
  55. Kennett GA. Effect of chronic administration of selective 5 hydroxytryptamine and noradrenaline uptake inhibitors on a putative index of 5 HT2C/2B receptor function. Neuropharmacology. 1994;33:1581-1588. https://doi.org/10.1016/0028-3908(94)90133-3
  56. Rasmusson AM. Low baseline and yohimbinestimulated plasma neuropeptide Y (NPY) levels in combat-related PTSD. Biological Psychiatry. 2000;47:526-539. 
  57. Oganesyan LP, Mkrtchyan GM, Boyadzhyan AS, Avetyan DG, Tadevosyan MYa, Sukiasyan SG. Markers of inflammation in post-traumatic stress disorder. Tsitokiny i vospalenie. 2012;11(1):42-45. (In Russ.).
  58. Smith EM, Cadet P, Stefano GB, Oppa MR, Hughes JrTK. IL-10 as a mediator in the HPA axis and brain. Journal of Neuroimmunology. 1999;100(1-2):140-148. 
  59. Sukiasyan SG, Tadevosyan MYa. Posttraumatic stress disorder among ex-combatants: from functional to organic. Psikhiatriya. 2011;1:59-69. (In Russ.).
  60. Sukiasyan SG, Tadevosyan MYa. The role of traumatic brain injury in the dynamics of combat post-traumatic stress disorder. Zhurn. nevrol. i psikhiatr. 2014;4:16-24. (In Russ.).
  61. Grunnet LG, Aikin R, Tonnesen MF, Paraskevas S, Blaabjerg L, Storling J, Rosenberg L, Billestrup N, Maysinger D, Mandrup-Poulsen T. Proinflammatory cytokines activate the intrinsic apoptotic pathway in beta-cells. Diabetes. 2009;58(8):1807-1815. https://doi.org/10.2337/db08-0178
  62. Oganesyan LP, Mkrtchyan GM, Sukiasyan SG, Boyajyan AS. Classic and Alternative Complement Cascades in Post-Traumatic Stress Disorder. Bulletin of Experimental Biology and Medicine. 2009;148(6):859-861.  https://doi.org/10.1007/s10517-010-0836-0
  63. Maes M, Lin Ai-hua, Delmeir L, Van Gastel A, Kenis G, De Jongh R, Bosmans E. Elevated serum interleukin-6 (IL-6) and IL-6 receptor concentrations in posttraumatic stress disorder following accidental man-made traumatic events. Biological Psychiatry. 1999;45(7):833-839.  https://doi.org/10.1016/S0006-3223(98)00131-0
  64. Cole DS, Morgan BP. Beyond lysis: how complement influences cell fate. Clinical Science. 2003;104:455-466.  https://doi.org/10.1042/CS20020362
  65. Duman RS. Pathophysiology of depression: the concept of synaptic plasticity. Eur Psychiatry. 2002;7(3):306-310.  https://doi.org/10.1016/S0924-9338(02)00654-5
  66. Kaplan GB, Vasterling JJ, Vedak PC. Brain-derived neurotrophic factor in traumatic brain injury, post-traumatic stress disorder, and their comorbid conditions: role in pathogenesis and treatment. Behav Pharmacol. 2010;21(5-6):427-437.  https://doi.org/10.1097/FBP.0b013e32833d8bc9
  67. Mkrtchyan GM, Boyadzhyan AS, Avetyan DG, Sukiasyan SG. Involvement of abnormal apoptosis in violation of synaptic plasticity in post-traumatic stress disorder. Zhurn nevrol i psikhiatr. 2013;113(1):26-29. (In Russ.).
  68. Gomazkov OA. Apoptosis of neuronal structures and the role of neurotrophic growth factors. Biochemical mechanisms of the effectiveness of brain peptide drugs. Zhurn nevrol i psikhiat. 2002;7:17-22. (In Russ.).
  69. Gill JM, Saligan L, Woods S, Page G. PTSD is associated with an excess of inflammatory immune activities. Perspect Psychiatr Care. 2009;45(4):262-277.  https://doi.org/10.1007/s11920-018-0977-9
  70. Munoz LE, Frey B, Pausch F, Baum W, Mueller RB, Brachvogel B, Poschl E, Rödel F, von der Mark K, Herrmann M, Gaipl US. Role of annexin A5 in modulation of the immune response against dying and dead cells. Curr Med Chem. 2007;14(3):271-277. 
  71. Flad HD, Grage-Griebenow E, Petersen F, Scheuerer B, Brandt E, Baran J, Pryjma J, Ernst M. The role of cytokines in monocyte apoptosis. Pathobiology. 1999;67(5-6):291-293.  https://doi.org/10.1159/000028082
  72. Miura M, Zhu H, Rotello R, Hartwieg EA, Yuan J. Induction of apoptosis in fibroblasts by IL-l-converting enzyme, mammalian homolog of the C elegans cell death gene ced-3. Cell. 1993;75:653-660.  https://doi.org/10.1007/BF01920106
  73. Boersma HH, Kietselaer BL, Stolk LM, Bennaghmouch A, Hofstra L, Narula J, Heidendal GA, Reutelingsperger CP. Past, present, and future of Annexin A5: from protein discovery to clinical applications. JNM. 2005;46(12):2035-2050. https://doi.org/10.1007/s00408-018-0159-x
  74. Huang GZ, Ujihara H, Takahashi S, Kaba H, Yagi T, Inoue S. Involvement of complexin II in synaptic plasticity in the CA1 region of the hippocampus: the use of complexin II-lacking mice. J Pharmacol (Jpn). 2000;84(2):179-187.  https://doi.org/10.1007/s11357-017-9981-y
  75. Von Kanel R, Hepp U, Kraemer B, Traber R, Keel M, Mica L, Schnyder U. Evidence for low-grade systemic proinflammatory activity in patients with posttraumatic stress disorder. J Psychiatr Res. 2007;41(9):744-752.  https://doi.org/10.1074/jbc.M500796200
  76. De Kloet CS. Elevated plasma corticotrophinreleasing hormone levels in veterans with posttraumatic stress disorder. Prog Brain Res. 2008;167:287-291. 
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.